Detalhe da pesquisa
1.
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma.
Acta Pharmacol Sin
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609562
2.
The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts.
Acta Pharmacol Sin
; 43(4): 1013-1023, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267347